Rising Incidence of Burn Injuries to Drive Global Amniotic Products Market

According to our new market research study, titled "Amniotic Products Market to 2028 - Global Analysis and Forecast - by Type, Application, and End User," the market is expected to grow from 1,164.32 million in 2022 to US$ 1,889.07 million by 2028. It is estimated to grow at a CAGR of 8.4% from 2022 to 2028. The report highlights trends prevailing in the market and drivers and hindrances pertaining to the global Amniotic Products market growth.

Amniotic products are the amniotic tissues and their parts that are used to provide protection and support for the injured tissue and other body parts. The amniotic membrane and suspension are two products that can be used for treatment. The amniotic membrane is the innermost layer of the placenta that nourishes and maintains an unborn child. Amniotic fluid is the liquid that surrounds the baby until delivery.

Factors, such as the rising incidence of burn injuries and the increasing number of traumatic wounds, are expected to boost the growth of the global amniotic products market during the forecast period. However, the market is likely to be impacted by complications and limitations associated with the use of amniotic membranes during the forecast period. More than 40 of the total burn treatment admissions in 2017 were classified as extremely serious, with treatment procedures costing more than US$ 118,455.50 (GBP 95,000) per person. Burns caused by home and industrial mishaps are on a rise in developing regions, such as Asia Pacific, Africa, and the Middle East, leading to a surge in the global market for amniotic products.

Biologic materials are used in various surgical procedures thanks to recent tissue harvesting, screening, and banking advancements. Burns, nerve regeneration, soft tissue reconstructive surgeries, ophthalmic surgeries, and diabetic foot ulcer surgeries are just a few of the applications for amniotic membranes. Amniotic membrane has been demonstrated to improve healing rates, reduce infection rates, shorten hospital stays, and decrease the number of dressing changes required in burn patients. Therefore, it has a lot of scopes to improve outcomes and save money. The amniotic membrane is helpful in chronic wounds, such as diabetic foot ulcers, and it holds tremendous potential for treating donor skin graft sites, wounds treated with skin grafts, and partial thickness burns. Thus, increasing burn cases are driving the amniotic product market.

North America holds the largest market share of the market, whereas Asia Pacific is the fastest-growing region. The amniotic products market in North America is expected to grow due to the surge in the aging population. The rising number of product approvals and developments is expected to create growth opportunities for the market. The amniotic products market in the US is expected to grow from US$ 336.64 million in 2022 to US$ 554.70 million by 2028 at a CAGR of 8.7% during the forecast period. The growth of the country's market is primarily driven by the increase in product development and the growing government support to improve the healthcare sector.

Approximately 30 million children and adolescents participate in youth sports in the US, leading to increased sports injuries among young American athletes. In the country, the market's growth is primarily driven by the increasing prevalence of arthritis, obesity, organ dislocation, and a rise in product launches by key players.

Furthermore, According to the CDC, approximately 12 million people 40 years and over in the US have vision impairment, including 1 million blind, 3 million who have vision impairment after correction, and 8 million who have vision impairment due to uncorrected refractive error. Approximately 6.8% of US children younger than 18 years have a diagnosed eye and vision condition. Nearly 3% of children younger than 18 years are blind or visually impaired and have trouble seeing even when wearing glasses or contact lenses.

The National Institute for Occupational Safety and Health (NIOSH) reports that about 2,000 US workers sustain job-related eye injuries requiring daily medical treatment. Thus, the rising eye diseases and associated surgeries will flourish the demand for amniotic products in the US market during the projected period.

Due to widespread lockdowns, denied wound care services, and cancelled or postponed elective surgeries, the COVID-19 outbreak had a negative impact on the amniotic products market in 2020. Elective procedures were denied (cancelled/postponed) in order to allocate or redirect scarce capacities and resources (such as hospital beds and patient care professionals) to COVID-19 patient care. In addition, to combat the increased number of COVID-19 cases, several countries imposed lockdowns and curfews. Patients were unable to visit hospitals, outpatient clinics, or clinics due to the lockdowns. The amniotic products industry is projected to be limited by this temporary suspension of non-emergent healthcare services. However, in the next years, demand for amniotic products is projected to increase.

In addition, the medical device industry was also facing the negative impact of the pandemic. As the COVID-19 pandemic continues to unfold, biopharmaceutical companies were finding difficulties in managing their operations. Many companies offering amniotic products have their business operations in the United States and businesses were adversely affected by the effects of a widespread COVID-19. This has disrupted and restricted the company's ability to distribute products, as well as temporary closures of the company's facilities. Also, to free-up limited space for the people who were treated for the virus, hospitals have postponed or canceled. For instance, as per the British Journal of Surgery published in May 2020 stated that orthopedic procedures were affected most, with 6.3 million operations canceled worldwide. Canceling elective surgeries to reduce exposure to COVID-19 in the hospital and operating rooms in intensive care units was negatively affecting the growth of the amniotic products market. Considering these it can be declared that the impact of COVID-19 on the amniotic products market was negative. However, after the establishment of COVID19 vaccines, the amniotic products market has also started to grow in North America.

Mimedx; Smith & Nephew; Integra Lifesciences; Stryker.; Organogenesis, Inc.; Katena Products. Inc.; Nuvision Biotherapies Ltd., Lucina Biosciences.; and Next Biosciences are the leading companies operating in the global amniotic products market.

By geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South and Central America).

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com